<DOC>
	<DOCNO>NCT01609075</DOCNO>
	<brief_summary>This observational , multicenter , retrospective/prospective study evaluate use Avastin ( bevacizumab ) clinical practice patient metastatic colorectal cancer . Patients initiated first-line treatment fluoropyrimidine-based chemotherapy Avastin follow 15 month .</brief_summary>
	<brief_title>An Observational Study Avastin ( Bevacizumab ) Patients With Metastatic Colorectal Cancer Italy ( BEWARE )</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Metastatic colorectal cancer Having initiate firstline treatment fluoropyrimidinebased chemotherapy plus Avastin 1 . September 2011 29 . February 2012 Availability test fro KRAS genotyping Participation clinical trial treatment Avastin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>